Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1077 (1 May), doi:10.1136/bmj.328.7447.1077-a
| The first 150 words of the full text of this article appear below. |
EDITORSometime in 2005 (but who knows exactly when), all the 100 000 or so doctors in the United Kingdom will be subject to revalidation.1-3
Despite the gravity of this change in the licensing of medical practitioners, there has been and still is little debate on this matter. Read through, for example, van Zwanenberg's references and you will have read just about all that has been published about it.2 Revalidation will affect the lives of every doctor registered with the GMC, yet few seem concerned about its process, implications, or repercussions. Compare the flood of responses to Wald and Law's paper on the Polypill with what is barely a trickle to the two papers on revalidation.1-4 Are we all distracted by contract worries, or are we burying our heads in the sand? Our new contracts will determine how much money goes into our pocket, but failing revalidation might render
Geoff Wong, general practitioner principal
The Surgery, 5 Daleham Gardens, London NW3 5BY g.wong@pcps.ucl.ac.uk